OC-1016

N/A

Report date: 2024/12/05 15:22:24

Base Information

Drug NameOC-1016
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionOsteogenesis stimulantsOsteopontin ligand
TargetsOsteopontin
Therapy Area/IndicationsMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrapharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrapharma Inc
Active IndicationsN/A
Inactive IndicationsMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A